Emil Kakkis

Ultragenyx Pharmaceutical, USA

Dr. Kakkis is best known for his work developing novel treatments for rare diseases and working on policy issues affecting rare disease treatment development through the EveryLife Foundation.  Emil is currently Chief Executive Officer, President and Founder of Ultragenyx Pharmaceutical, a company with four approved therapies for rare diseases and 20 different disease treatments in development. Dr. Kakkis has received numerous awards including the Roscoe O Brady Award for innovation from the WORLD Symposium and the Henri Termeer Visionary Leader Award from BIO, the biotechnology industry organization.

Broadcast Time Zone is US East Coast Time (EST)

Approximately one week before the Conference, all registered delegates will receive an invitation with personal link to set their profile and enter the virtual Conference platform.  Your personal link will only be valid until the end of the Conference.  In order to view the Conference lectures and panel discussions, delegates must enter the virtual Conference platform and set their profile before the end of the Conference.